Amanullah Khan
Hematology & Oncology · McKinney, TXNPI 1114922531
Payments from drug & device makers
Across 102 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$221
- Tactile Systems Technology Inc$133
- Pfizer$112
- Bristol Myers Squibb$111
- Merck$105
- Astellas Pharma US Inc$98
- plus $850 from 29 others
What the payments were for
- Food & beverage$1,60498%
- Education$262%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 21 | $221 |
| Tactile Systems Technology Inc | 10 | $133 |
| Pfizer | 7 | $112 |
| Bristol Myers Squibb | 5 | $111 |
| Merck | 6 | $105 |
| Astellas Pharma US Inc | 5 | $98 |
| Puma Biotechnology, Inc. | 5 | $82 |
| Incyte Corporation | 3 | $63 |
| Sanofi | 2 | $47 |
| Medtronic(2 entities) | 3 | $45 |
| Genentech USA, Inc. | 3 | $43 |
| Bayer | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Gilead | 2 | $37 |
| Rigel Pharmaceuticals, Inc. | 2 | $32 |
| Epizyme, Inc. | 2 | $31 |
| Johnson & Johnson | 2 | $28 |
| Novartis | 2 | $27 |
| Boehringer Ingelheim | 1 | $27 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $26 |
| AbbVie | 1 | $24 |
| Lilly USA, LLC | 2 | $24 |
| Myriad Genetic Laboratories, Inc. | 1 | $22 |
| Dova Pharmaceuticals | 1 | $21 |
| Agios Pharmaceuticals, Inc. | 1 | $20 |
| Amgen | 1 | $20 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| Blue Earth Diagnostics | 1 | $18 |
| Mylan Institutional Inc. | 1 | $17 |
| Clovis Oncology, Inc. | 1 | $16 |
| Blueprint Medicines Corporation | 1 | $15 |
| Dendreon Pharmaceuticals LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
How this compares
$1,630 in reported general payments places this provider in the 25th percentile of 838 hematology & oncology providers in Texas.
Other hematology & oncology in McKinney
- Elias JabbourHouston$264.1M
- Luhua WangHouston$79.6M
- Courtney DinardoHouston$74M
- Jorge Cortes-FrancoHouston$59.4M
- William WierdaHouston$58.7M
- Koji SasakiHouston$39.2M
- Kyriakos PapadopoulosSan Antonio$18.5M
- Loretta NastoupilHouston$18.3M
- Christopher FlowersHouston$17.2M
- Drew RascoSan Antonio$14.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.